A trial of an AI algorithm that uses retina images to evaluate the risk for atherosclerotic cardiovascular disease ...
In eye clinics and clinical trials, doctors increasingly rely on patients' own reports of how eye disease and treatment ...
Diabetic retinopathy (DR) is a common chronic complication of diabetes mellitus. Endothelin-1 (ET-1) has been identified as a key regulator of various ocular functions, including vascular perfusion, ...
The treatment of diabetic retinopathy (DR) and diabetic macular edema (DME) has evolved significantly since the introduction of first effective treatments 50 years ago. Like with any disease, ...
Individuals with type 2 diabetes — with or without retinopathy — had higher risks for incident Alzheimer’s disease and dementia than those without the blood sugar disorder. Among patients with ...
Share on Pinterest Tirzepatide may help lower the risk of diabetic retinopathy, a diabetes complication that can lead to vision loss. Douglas Sacha/Getty Images Weight loss medications Mounjaro and ...
Abstract: Diabetic Retinopathy (DR) is a serious complication of diabetes and a major cause of vision loss. The damage it causes to the retina is permanent, which makes early detection and accurate ...
The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell ...
Quadrant-specific changes in superficial vascular complex vessel density, particularly in the 16- to 21-mm temporal region, are potential early biomarkers for diabetic retinopathy. Widefield ...
Tear fluid is emerging as an attractive source of diagnostic information because it can be collected easily and non-invasively. Changes in tear composition often reflect underlying physiological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results